Welcome Notes

Dear Esteemed Colleagues, Researchers, and Innovators,

It is with great honor and anticipation that we welcome you to the 29th International Conference on Diabetes, Endocrinology, and Healthcare, to be held in the historic and inspiring city of Paris, France, on November 10–11, 2025.

This globally recognized event brings together leading scientists, clinicians, policy-makers, and healthcare professionals committed to advancing the science and practice of diabetes and endocrine care. Over two enriching days, attendees will engage with cutting-edge research, novel therapeutic strategies, and comprehensive approaches to improving patient outcomes.

The conference will feature distinguished keynote addresses, expert-led panel discussions, and interactive sessions designed to foster meaningful dialogue and collaboration across disciplines. It is an unparalleled platform for sharing knowledge, forging partnerships, and inspiring innovation in the fields of diabetes, endocrinology, and holistic healthcare.

We invite you to join this transformative gathering and contribute to shaping the future of endocrine and metabolic health. Your insights, expertise, and engagement are vital to driving progress and making a lasting impact on global healthcare.

We look forward to welcoming you to Paris for this exceptional event.

Warm regards,
Organizing Committee
29th International Conference on Diabetes, Endocrinology, and Healthcare

About Diabetes, Endocrinology and Healthcare

The 29th International Conference on Diabetes, Endocrinology, and Healthcare, scheduled for November 10–11, 2025, in the iconic city of Paris, France, will serve as a premier platform for advancing the theme:
"Advancing Global Perspectives in Diabetes and Endocrinology through Innovation and Collaboration."

This prestigious gathering will unite leading researchers, healthcare professionals, policy-makers, and academic scholars from across the globe to discuss cutting-edge advancements in diabetes care, endocrinology, and transformative healthcare strategies. Building on the momentum of previous successful editions, this conference aims to:

• Examine the global burden and emerging trends in diabetes and endocrine disorders, with a focus on innovative treatments and translational research.

• Explore how healthcare systems worldwide are evolving post-pandemic, emphasizing prevention, remission strategies, and enhanced treatment modalities.

• Showcase the integration of next-generation technologies—including artificial intelligence, telehealth, and precision medicine—into endocrine and diabetes care.

Key topics to be addressed include:

• Breakthrough strategies for managing and achieving remission in Type 2 diabetes.

• Innovations in secondary care and effective approaches to managing diabetes-related complications.

• Advances in hormonal therapies and emerging frontiers in endocrinology research.

With projections indicating that over 201.8 million people in Asia alone could be affected by diabetes by 2035, the urgency to elevate prevention, improve care delivery, and expand global education has never been greater.

We invite you to join this pivotal event in Paris, where thought leaders and changemakers will come together to shape the future of endocrine health and diabetes care. Be part of the innovation, collaboration, and transformation that this field urgently needs.

Session & Tracks

Track 1: Endocrine and Disorders
Track 2: Types of Diabetes
Track 3: Diabetes Mellitus
Track 4: Diabetes Symptoms and Complications
Track 5: Obesity and Metabolism for Diabetes
Track 6: Diabetic Retinopathy
Track 7: Diabetic Nephropathy
Track 8: Diabetic Nutrition and Diet
Track 9: Diabetes Etiology
Track 10: Diabetes: Advanced Technologies and Treatments
Track 11: Blood Glucose Dynamics and Monitoring
Track 12: Emerging Treatments and Technologies
Track 13: Nanotechnology in Diabetes Treatment
Track 14: Prediabetes to Late-Stage Complicated Diabetes
Track 15: Clinical Care and Education
Track 16: COVID-19 and Diabetes, Post-COVID Diabetes
Track 17: Diabetes and Cardiology
Track 18: Risks and Benefits of New Therapies
Track 19: Transplantation and Artificial Pancreas
Track 20: Insulin Resistance & Insulin therapy
Track 21: Mental Health and Diabetes
Track 22: Artificial Intelligence: The Future for Diabetes Care

Target Audience

•  Endocrinologists 
•  Diabetologists 
•  Gynaecologist Neurologists
•  Ophthalmologists
•   Oncologists
•   Physicians
•   Nutritionists/Dieticians
•   Diabetes Health Professionals
•   Medical faculties
•   Academic researchers
•   Research Institutes
•   Endocrinology Societies & Associations
•   Diabetes Societies & Associations
•   Obesity Societies & Associations
•   Pharmaceutical corporations
•   Researchers
•   Endocrinology, polygenic disorder & Metabolism Associations and Societies |
•   Business Entrepreneurs
•   Training Institutes
•    Manufacturing Medical Devices corporations 

Benefits of Attending

• Global Networking Opportunities
• Collaborative Approaches to Innovation
• Access to Expertise
• Comprehensive Knowledge Exchange
• Problem-Solving and Strategic Dialogues
• Professional Development
• Collaborative Learning Environment
• Access to Multidisciplinary Perspectives
• Workshops and Practical Applications
• Stay Ahead of Industry Trends
• Contribute to Global Healthcare Goals
• Platform for Presenting Your Work
• Inspiration and Motivation

Attending this conference ensures a well-rounded experience that combines professional growth, innovative learning, and opportunities to create meaningful contributions to the field of diabetes and endocrinology.

Market Overview

Global Diabetes Market Overview

The global diabetes market is anticipated to grow at a compound annual growth rate (CAGR) of 7.6% during the forecast period of 2018–2023. This market is categorized by diabetes type, drug class, and diabetic devices. Among diabetic devices, blood glucose meters hold the largest market share, outperforming insulin delivery systems such as syringes and pen injectors.

The segment of continuous glucose monitoring systems (CGMS) is expected to witness the fastest growth, fuelled by increased adoption and technological advancements. The United States allocates approximately 11% of its healthcare expenditures to diabetes management. Meanwhile, India and China remain the most affected regions, with over 120 million diabetes patients, a significant proportion of whom are undiagnosed or lack access to basic treatment options.

Major market players are striving to develop advanced solutions such as the artificial pancreas, which is currently in prototype stages using CGMS devices combined with insulin pumps. Commercialization of the artificial pancreas is projected within the next decade, revolutionizing diabetes care. Read More .

Past Conference

The 28th International Conference on Diabetes, Endocrinology, and Healthcare was successfully held in Dubai, UAE, on November 21-22, 2024, under the theme "Innovation in Diabetes, Cutting-edge Technologies, and the Latest Research." This event brought together a distinguished group of global researchers, healthcare professionals, and industry leaders to discuss the most recent advancements and challenges in the field.

Highlights of the 2024 Conference

Renowned Keynote Speakers:
The conference featured influential keynote addresses by:

·         Dr. Michael Turner (USA), an authority on diabetes technologies and artificial pancreas systems.

·         Prof. Ayesha Khan (UK), specializing in endocrinology and diabetes-related complications.

·         Dr. Rahul Mehta (India), a leader in Type 2 diabetes prevention and remission strategies.

Scientific Tracks and Sessions:
Over 40 specialized sessions explored diverse topics, including:

·         Advances in diabetes diagnostics and treatment.

·         Innovations in endocrinology and metabolic disorders.

·         Impact of COVID-19 on Type 2 diabetes care.

·         Latest breakthroughs in CGMS and insulin delivery systems.

·         Emerging trends in personalized diabetes management and telemedicine.

Young Researcher Forum:
The event provided an excellent platform for emerging scientists to showcase their work. Highlights included groundbreaking studies on biomarkers for early detection of diabetes complications and AI-powered tools for endocrinology research.

Networking and Collaborations:
The conference welcomed attendees from over 45 countries, fostering meaningful discussions and interdisciplinary collaborations between academia, industry, and clinical sectors.

Workshops and Interactive Sessions:
Practical workshops on:

·         Real-world applications of digital diabetes tools.

·         Integration of AI and machine learning in endocrinology.

·         Strategies for effective diabetes care in low-resource settings.

Notable Achievements

·         Facilitated numerous global partnerships to advance diabetes research and care.

·         Generated significant interest in emerging technologies such as artificial pancreas systems and digital diabetes management platforms.

·         Provided actionable insights for healthcare professionals on improving patient outcomes.

Feedback and Future Goals

The success of the 28th conference has created high expectations for the 29th International Conference on Diabetes, Endocrinology, and Healthcare, scheduled for January 27-28, 2025, in Dubai, UAE.

Building on the success of the previous conference, the upcoming event aims to:

·         Expand the scope to include areas such as regenerative medicine and bioinformatics.

·         Encourage wider global participation, with a focus on emerging markets and developing countries.

·         Showcase pioneering research and provide a robust platform for meaningful collaborations across disciplines.

The 28th International Conference highlighted the transformative power of innovation, collaboration, and dedication in tackling global diabetes and endocrinology challenges. We look forward to continuing this legacy in 2025.

Important Guidelines:

Abstract submission deadline: Oct 10, 2025

First Phase Registration: August 28, 2025

Early Bird Registration Deadline: Sept 28, 2025

Book your slot: HERBAL DIABETES 2025

Email: Program Manager at herbaldiabetes@meetingsnexpo.com

WhatsApp at 443308221359  with details of the 5 participants.

Abstract submission guidelines for Herbal Diabetes 2025.
If you choose to participate in this conference, you need to submit an abstract.
The abstract should carry the summary of a research.
Abstract should be submitted either through e-mail or using the link given below.
Abstracts should be based on any areas as listed in this website as sessions/tracks.

Note: The review process for the submitted abstract will take 2-3 working days.

Submitting abstract will be published in conference proceedings in the conference supporting journal

Abstract Submission website: HERBAL DIABETES  ABSTRACT SUBMISSION
Contact us:
Event Manager| HERBAL DIABETES 2025
Email Id:  herbaldiabetes@meetingsnexpo.com